Board Meeting13 Aug 2026, 03:58 pm
Titan Biotech Ltd Board Approves Unaudited Q1 FY27 Results
AI Summary
Titan Biotech Ltd announced that its Board of Directors, in a meeting held on August 13, 2026, has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee prior to board approval. The company has also submitted the Limited Review Report issued by its statutory auditors. The detailed financial results and the review report will be available on the company's website and the BSE India website.
Key Highlights
- Board meeting held on August 13, 2026.
- Unaudited financial results for Q1 FY27 approved.
- Both standalone and consolidated results were approved.
- Audit Committee reviewed the financial results.
- Limited Review Report from statutory auditors enclosed.
Price Impact
More from TITANBIO
More in Board Meeting